Curis
CRIS
#10187
Rank
A$18.51 M
Marketcap
A$1.35
Share price
-5.93%
Change (1 day)
-71.09%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$60.69 Million, an increase over its 2023 earnings that were of -A$64.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-16.11%
2024 -A$60.69 Million-5.77%
2023 -A$64.41 Million-13.1%
2022 -A$74.11 Million27.52%
2021 -A$58.12 Million65.09%
2020 -A$35.21 Million-9.1%
2019 -A$38.73 Million-4.73%
2018 -A$40.65 Million-41.95%
2017 -A$70.02 Million-14.37%
2016 -A$81.77 Million3.55%
2015 -A$78.97 Million271.52%
2014 -A$21.26 Million76.64%
2013 -A$12.04 Million
2011 -A$10.22 Million27.76%
2010 -A$8 Million-43.87%
2009 -A$14.26 Million-23.44%
2008 -A$18.62 Million56.66%
2007 -A$11.89 Million-16.71%
2006 -A$14.27 Million-36.92%
2005 -A$22.62 Million156.25%
2004 -A$8.83 Million-37.24%
2003 -A$14.07 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.81 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.39 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$87.8 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.23 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.37 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.14 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA